Health2Sync, Sanofi partner to digitise insulin management in Japan

Industry Knowledge International Trend

Taiwan-based digital health startup Health2Sync and French multinational pharmaceutical firm Sanofi have signed another partnership to bring digital solutions for insulin management to Japan.

A recent study suggesting that the basal insulin dose may be further optimised through appropriate approaches. However, continuously recording blood glucose levels can be cumbersome for diabetic patients, who are already struggling to control their disease in an unstable environment.

Health2Sync and Sanofi claim their digital solutions will help improve insulin management among healthcare providers and patients with diabetes.